Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2012 Jun 21;3(6):470–480. doi: 10.1007/s13238-012-2932-6

Generation of Calhm1 knockout mouse and characterization of calhm1 gene expression

Junbing Wu 1,2, Shengyi Peng 1,2, Rong Wu 1,2, Yumin Hao 1,2, Guangju Ji 1, Zengqiang Yuan 1,✉
PMCID: PMC4875489  PMID: 22723178

Abstract

Alzheimer’s disease (AD) is the most common neurodegenerative disease among elderly people worldwide. Several genes have been validated to be associated with AD, and calcium homeostasis modulator 1 (Calhm1) is the latest suspected one. To investigate the biological and pathological function of Calhm1 systematically, we generated a Calhm1 conventional knockout mouse. However, both the male and female of elderly Calhm1 knockout (KO) mice showed similar ability to their wild type littermates in spatial learning and memory retrieving. Surprisingly, we found that Calhm1 mRNA could not be detected in mouse brains at different ages, although it is expressed in the human brain tissues. We further found that CpG islands (CGIs) of both mouse and human Calhm1 were hypermethylated, whereas CGI of mouse Calhm2 was hypomethylated. In addition, transcriptional active marker H3K4Di occupied on promoters of human Calhm1 and mouse Calhm2 at a considerable level in brain tissues, while the occupancy of H3K4Di on promoter of mouse Calhm1 was rare. In sum, we found that mouse Calhm1 was of rare abundance in brain tissues. So it might not be suitable to utilize the knockout murine model to explore biological function of Calhm1 in the pathogenesis of AD.

Keywords: Alzheimer’s disease, calcium homeostasis modulator, methylation, transcription

References

  1. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer’s disease. Lancet. 2011;377:1019–1031. doi: 10.1016/S0140-6736(10)61349-9. [DOI] [PubMed] [Google Scholar]
  2. Beecham G.W., SchnetzBoutaud N., Haines J.L., PericakVance M.A. CALHM1 polymorphism is not associated with late-onset Alzheimer disease. Ann Hum Genet. 2009;73:379–381. doi: 10.1111/j.1469-1809.2009.00509.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron. 2010;68:270–281. doi: 10.1016/j.neuron.2010.10.013. [DOI] [PubMed] [Google Scholar]
  4. Boada M., Antunez C., Lopez-Arrieta J., Galan J.J., Moron F.J., Hernandez I., Marin J., Martinez-Lage P., Alegret M., Carrasco J.M., et al. CALHM1 P86L polymorphism is associated with late-onset Alzheimer’s disease in a recessive model. J Alzheimers Dis. 2010;20:247–251. doi: 10.3233/JAD-2010-1357. [DOI] [PubMed] [Google Scholar]
  5. Brandes J.C., Carraway H., Herman J.G. Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter. Oncogene. 2007;26:6229–6237. doi: 10.1038/sj.onc.1210433. [DOI] [PubMed] [Google Scholar]
  6. Coffee, B. (2009). Methylation-specific PCR. Curr Protoc Hum Genet Chapter 10, Unit 10 16. [DOI] [PubMed]
  7. Cui P.J., Zheng L., Cao L., Wang Y., Deng Y.L., Wang G., Xu W., Tang H.D., Ma J.F., Zhang T., et al. CALHM1 P86L polymorphism is a risk factor for Alzheimer’s disease in the Chinese population. J Alzheimers Dis. 2010;19:31–35. doi: 10.3233/JAD-2010-1207. [DOI] [PubMed] [Google Scholar]
  8. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25:1010–1022. doi: 10.1101/gad.2037511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dreses-Werringloer U., Lambert J.C., Vingtdeux V., Zhao H., Vais H., Siebert A., Jain A., Koppel J., Rovelet-Lecrux A., Hannequin D., et al. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer’s disease risk. Cell. 2008;133:1149–1161. doi: 10.1016/j.cell.2008.05.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research. 2002;30:207–210. doi: 10.1093/nar/30.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349–1356. doi: 10.1001/jama.1997.03550160069041. [DOI] [PubMed] [Google Scholar]
  12. Feng R., Rampon C., Tang Y.P., Shrom D., Jin J., Kyin M., Sopher B., Miller M.W., Ware C.B., Martin G.M., et al. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron. 2001;32:911–926. doi: 10.1016/S0896-6273(01)00523-2. [DOI] [PubMed] [Google Scholar]
  13. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005;15:490–495. doi: 10.1016/j.gde.2005.08.002. [DOI] [PubMed] [Google Scholar]
  14. Giedraitis V., Glaser A., Sarajarvi T., Brundin R., Gunnarsson M.D., Schjeide B.M., Tanzi R.E., Helisalmi S., Pirttila T., Kilander L., et al. CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid. Neurosci Lett. 2010;469:265–267. doi: 10.1016/j.neulet.2009.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature. 1991;349:704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  16. Harris F.M., Brecht W.J., Xu Q., Tesseur I., Kekonius L., Wyss-Coray T., Fish J.D., Masliah E., Hopkins P.C., Scearce-Levie K., et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer’s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A. 2003;100:10966–10971. doi: 10.1073/pnas.1434398100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Inoue K., Tanaka N., Yamashita F., Sawano Y., Asada T., Goto Y. The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:532–535. doi: 10.1002/ajmg.b.31014. [DOI] [PubMed] [Google Scholar]
  18. Kunert-Keil C., Bisping F., Kruger J., Brinkmeier H. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics. 2006;7:159. doi: 10.1186/1471-2164-7-159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci. 2002;3:862–872. doi: 10.1038/nrn960. [DOI] [PubMed] [Google Scholar]
  20. Laird C.D. Chromatid structure: relationship between DNA content and nucleotide sequence diversity. Chromosoma. 1971;32:378–406. doi: 10.1007/BF00285251. [DOI] [PubMed] [Google Scholar]
  21. Lambert J.C., Sleegers K., Gonzalez-Perez A., Ingelsson M., Beecham G.W., Hiltunen M., Combarros O., Bullido M.J., Brouwers N., Bettens K., et al. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer’s disease: a meta-analysis study. J Alzheimers Dis. 2010;22:247–255. doi: 10.3233/JAD-2010-100933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science. 1995;269:973–977. doi: 10.1126/science.7638622. [DOI] [PubMed] [Google Scholar]
  23. Liu P., Jenkins N.A., Copeland N.G. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 2003;13:476–484. doi: 10.1101/gr.749203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Matevossian, A., and Akbarian, S. (2008). A chromatin assay for human brain tissue. J Vis Exp. [DOI] [PMC free article] [PubMed]
  25. Minster R.L., Demirci F.Y., DeKosky S.T., Kamboh M.I. No association between CALHM1 variation and risk of Alzheimer disease. Hum Mutat. 2009;30:E566–569. doi: 10.1002/humu.20989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Moyer B.D., Hevezi P., Gao N., Lu M., Kalabat D., Soto H., Echeverri F., Laita B., Yeh S.A., Zoller M., et al. Expression of genes encoding multi-transmembrane proteins in specific primate taste cell populations. PLoS One. 2009;4:e7682. doi: 10.1371/journal.pone.0007682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nacmias B., Tedde A., Bagnoli S., Lucenteforte E., Cellini E., Piaceri I., Guarnieri B.M., Bessi V., Bracco L., Sorbi S. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer’s disease. J Alzheimers Dis. 2010;20:37–41. doi: 10.3233/JAD-2010-1345. [DOI] [PubMed] [Google Scholar]
  28. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992;89:4471–4475. doi: 10.1073/pnas.89.10.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rozen S., Skaletsky H. Primer3 on the www for general users and for biologist programmers. Methods Mol Biol. 2000;132:365–386. doi: 10.1385/1-59259-192-2:365. [DOI] [PubMed] [Google Scholar]
  30. Sambrook, J., and Russell, D.W. (2001). Molecular cloning: a laboratory manual, Vol 2 (CSHL press).
  31. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43:1467–1472. doi: 10.1212/WNL.43.8.1467. [DOI] [PubMed] [Google Scholar]
  32. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 1997;89:629–639. doi: 10.1016/S0092-8674(00)80244-5. [DOI] [PubMed] [Google Scholar]
  33. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature. 1995;375:754–760. doi: 10.1038/375754a0. [DOI] [PubMed] [Google Scholar]
  34. Shibata N., Kuerban B., Komatsu M., Ohnuma T., Baba H., Arai H. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer’s disease in a Japanese population. J Alzheimers Dis. 2010;20:417–421. doi: 10.3233/JAD-2010-1380. [DOI] [PubMed] [Google Scholar]
  35. Sleegers K., Brouwers N., Bettens K., Engelborghs S., van Miegroet H., De Deyn P.P., Van Broeckhoven C. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum Mutat. 2009;30:E570–574. doi: 10.1002/humu.20990. [DOI] [PubMed] [Google Scholar]
  36. Tanzi R.E. A genetic dichotomy model for the inheritance of Alzheimer’s disease and common age-related disorders. J Clin Invest. 1999;104:1175–1179. doi: 10.1172/JCI8593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1:848–858. doi: 10.1038/nprot.2006.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yu H., Saura C.A., Choi S.Y., Sun L.D., Yang X., Handler M., Kawarabayashi T., Younkin L., Fedeles B., Wilson M.A., et al. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron. 2001;31:713–726. doi: 10.1016/S0896-6273(01)00417-2. [DOI] [PubMed] [Google Scholar]
  39. Zhang Z., Schwartz S., Wagner L., Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol. 2000;7:203–214. doi: 10.1089/10665270050081478. [DOI] [PubMed] [Google Scholar]
  40. Zheng H., Jiang M., Trumbauer M.E., Sirinathsinghji D.J., Hopkins R., Smith D.W., Heavens R.P., Dawson G.R., Boyce S., Conner M.W., et al. beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 1995;81:525–531. doi: 10.1016/0092-8674(95)90073-X. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES